May 15, 2020

TCR² Therapeutics to Present Data on PD-1 Switch TRuC Enhancement at American Association for Cancer Research (AACR) Virtual Meeting 2020

May 14, 2020

TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 04, 2020

TCR² Therapeutics Announces Veteran Finance Executive Stephen Webster Joins its Board of Directors

Apr 15, 2020

TCR² Therapeutics Announces Immuno-Oncology Pioneer Dr. Axel Hoos Joins its Board of Directors

Apr 03, 2020

TCR² Therapeutics to Present at the Goldman Sachs Cell Therapy Day

Mar 30, 2020

TCR² Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Feb 18, 2020

TCR² Therapeutics to Participate in Two Upcoming Conferences in February

Feb 03, 2020

TCR² Therapeutics to Present an Allogeneic Construct at the Keystone Symposia Conference on Emerging Cellular Therapies: Cancer and Beyond

Jan 07, 2020

TCR² Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference